Gene | SNPs ID | Minor Alleles | Major Alleles | p-value | FDR | MAF | OR (95% CI) | p-value* | OR (95% CI)* | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Affected | Unaffected | Affected | Unaffected | |||||||||
N (%) | N (%) | N (%) | N (%) | |||||||||
Survivors < 83.8% predicted \( \dot{\mathrm{V}} \) O2 peak | TTN | rs6723526 | 33 (14.47) | 195 (85.53) | 9 (4.55) | 189 (95.45) | 0.0005 | 0.04 | 0.1 | 3.55 (1.66–7.63) | 0.0006 | 4.47 (1.89–10.53) |
Female survivors < 83.8% predicted \( \dot{\mathrm{V}} \) O2 peak | LEPR | rs1137100 | 22 (17.19) | 106 (82.81) | 34 (37.78) | 56 (62.22) | 0.0008 | 0.03 | 0.25 | 0.34 (0.18–0.64) | 0.003 | 0.33 (0.15–0.68) |
IGFBP1 | rs4619 | 43 (33.59) | 85 (66.41) | 51 (56.67) | 39 (43.33) | 0.0008 | 0.03 | 0.42 | 0.39 (0.22–0.67) | 0.01 | 0.46(0.24–0.86) | |
ENO3 | rs238239 | 41 (32.54) | 85 (67.46) | 46 (53.49) | 40 (46.51) | 0.002 | 0.05 | 0.4 | 0.42 (0.24–0.74) | 0.005 | 0.34 (0.16–0.73) |